Literature DB >> 30523454

Differentiation of clear cell and non-clear cell renal cell carcinomas by all-relevant radiomics features from multiphase CT: a VHL mutation perspective.

Zhi-Cheng Li1, Guangtao Zhai2, Jinheng Zhang1, Zhongqiu Wang3, Guiqin Liu4, Guang-Yu Wu5, Dong Liang1, Hairong Zheng1.   

Abstract

OBJECTIVES: To develop a radiomics model with all-relevant imaging features from multiphasic computed tomography (CT) for differentiating clear cell renal cell carcinoma (ccRCC) from non-ccRCC and to investigate the possible radiogenomics link between the imaging features and a key ccRCC driver gene-the von Hippel-Lindau (VHL) gene mutation.
METHODS: In this retrospective two-center study, two radiomics models were built using random forest from a training cohort (170 patients), where one model was built with all-relevant features and the other with minimum redundancy maximum relevance (mRMR) features. A model combining all-relevant features and clinical factors (sex, age) was also built. The radiogenomics association between selected features and VHL mutation was investigated by Wilcoxon rank-sum test. All models were tested on an independent validation cohort (85 patients) with ROC curves analysis.
RESULTS: The model with eight all-relevant features from corticomedullary phase CT achieved an AUC of 0.949 and an accuracy of 92.9% in the validation cohort, which significantly outperformed the model with eight mRMR features (seven from nephrographic phase and one from corticomedullary phase) with an AUC of 0.851 and an accuracy of 81.2%. Combining age and sex did not benefit the performance. Five out of eight all-relevant features were significantly associated with VHL mutation, while all eight mRMR features were significantly associated with VHL mutation (false discovery rate-adjusted p < 0.05).
CONCLUSIONS: All-relevant features in corticomedullary phase CT can be used to differentiate ccRCC from non-ccRCC. Most subtype-discriminative imaging features were found to be significantly associated with VHL mutation, which may underlie the molecular basis of the radiomics features. KEY POINTS: • All-relevant features in corticomedullary phase CT can be used to differentiate ccRCC from non-ccRCC with high accuracy. • Most RCC-subtype-discriminative CT features were associated with the key RCC-driven gene-the VHL gene mutation. • Radiomics model can be more accurate and interpretable when the imaging features could reflect underlying molecular basis of RCC.

Entities:  

Keywords:  Diagnostic imaging; Radiomics; Renal cell carcinomas; von Hippel-Lindau disease

Mesh:

Substances:

Year:  2018        PMID: 30523454     DOI: 10.1007/s00330-018-5872-6

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  39 in total

1.  Renal mass biopsy to guide treatment decisions for small incidental renal tumors: a cost-effectiveness analysis.

Authors:  Pari V Pandharipande; Debra A Gervais; Rebecca I Hartman; Mukesh G Harisinghani; Adam S Feldman; Peter R Mueller; G Scott Gazelle
Journal:  Radiology       Date:  2010-09       Impact factor: 11.105

2.  Feature selection based on mutual information: criteria of max-dependency, max-relevance, and min-redundancy.

Authors:  Hanchuan Peng; Fuhui Long; Chris Ding
Journal:  IEEE Trans Pattern Anal Mach Intell       Date:  2005-08       Impact factor: 6.226

3.  mRMRe: an R package for parallelized mRMR ensemble feature selection.

Authors:  Nicolas De Jay; Simon Papillon-Cavanagh; Catharina Olsen; Nehme El-Hachem; Gianluca Bontempi; Benjamin Haibe-Kains
Journal:  Bioinformatics       Date:  2013-07-03       Impact factor: 6.937

4.  Outcomes of small renal mass needle core biopsy, nondiagnostic percutaneous biopsy, and the role of repeat biopsy.

Authors:  Michael J Leveridge; Antonio Finelli; John R Kachura; Andrew Evans; Hannah Chung; Daniel A Shiff; Kimberly Fernandes; Michael A S Jewett
Journal:  Eur Urol       Date:  2011-06-24       Impact factor: 20.096

Review 5.  Targeted therapies and the treatment of non-clear cell renal cell carcinoma.

Authors:  J Bellmunt; J Dutcher
Journal:  Ann Oncol       Date:  2013-04-26       Impact factor: 32.976

6.  Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma.

Authors:  John C Cheville; Christine M Lohse; Horst Zincke; Amy L Weaver; Michael L Blute
Journal:  Am J Surg Pathol       Date:  2003-05       Impact factor: 6.394

7.  Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma.

Authors:  A Ari Hakimi; Ying-Bei Chen; James Wren; Mithat Gonen; Omar Abdel-Wahab; Adriana Heguy; Han Liu; Shugaku Takeda; Satish K Tickoo; Victor E Reuter; Martin H Voss; Robert J Motzer; Jonathan A Coleman; Emily H Cheng; Paul Russo; James J Hsieh
Journal:  Eur Urol       Date:  2012-09-27       Impact factor: 20.096

8.  Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.

Authors:  Jonathan R Young; Daniel Margolis; Steven Sauk; Allan J Pantuck; James Sayre; Steven S Raman
Journal:  Radiology       Date:  2013-02-04       Impact factor: 11.105

9.  Comprehensive molecular characterization of clear cell renal cell carcinoma.

Authors: 
Journal:  Nature       Date:  2013-06-23       Impact factor: 49.962

10.  Gene selection and classification of microarray data using random forest.

Authors:  Ramón Díaz-Uriarte; Sara Alvarez de Andrés
Journal:  BMC Bioinformatics       Date:  2006-01-06       Impact factor: 3.169

View more
  16 in total

1.  A CT-based radiomics nomogram for differentiation of renal angiomyolipoma without visible fat from homogeneous clear cell renal cell carcinoma.

Authors:  Pei Nie; Guangjie Yang; Zhenguang Wang; Lei Yan; Wenjie Miao; Dapeng Hao; Jie Wu; Yujun Zhao; Aidi Gong; Jingjing Cui; Yan Jia; Haitao Niu
Journal:  Eur Radiol       Date:  2019-09-10       Impact factor: 5.315

Review 2.  A primer on texture analysis in abdominal radiology.

Authors:  Natally Horvat; Joao Miranda; Maria El Homsi; Jacob J Peoples; Niamh M Long; Amber L Simpson; Richard K G Do
Journal:  Abdom Radiol (NY)       Date:  2021-11-26

3.  Shape and texture-based radiomics signature on CT effectively discriminates benign from malignant renal masses.

Authors:  Felix Y Yap; Bino A Varghese; Steven Y Cen; Darryl H Hwang; Xiaomeng Lei; Bhushan Desai; Christopher Lau; Lindsay L Yang; Austin J Fullenkamp; Simin Hajian; Marielena Rivas; Megha Nayyar Gupta; Brian D Quinn; Manju Aron; Mihir M Desai; Monish Aron; Assad A Oberai; Inderbir S Gill; Vinay A Duddalwar
Journal:  Eur Radiol       Date:  2020-08-15       Impact factor: 5.315

Review 4.  Radiomics to better characterize small renal masses.

Authors:  Teele Kuusk; Joana B Neves; Maxine Tran; Axel Bex
Journal:  World J Urol       Date:  2021-01-26       Impact factor: 4.226

5.  A Non-Invasive Scoring System to Differential Diagnosis of Clear Cell Renal Cell Carcinoma (ccRCC) From Renal Angiomyolipoma Without Visible Fat (RAML-wvf) Based on CT Features.

Authors:  Xiao-Jie Wang; Bai-Qiang Qu; Jia-Ping Zhou; Qiao-Mei Zhou; Yuan-Fei Lu; Yao Pan; Jian-Xia Xu; You-You Miu; Hong-Qing Wang; Ri-Sheng Yu
Journal:  Front Oncol       Date:  2021-04-23       Impact factor: 6.244

Review 6.  The application of radiomics in predicting gene mutations in cancer.

Authors:  Yana Qi; Tingting Zhao; Mingyong Han
Journal:  Eur Radiol       Date:  2022-01-20       Impact factor: 5.315

7.  Discriminating Origin Tissues of Tumor Cell Lines by Methylation Signatures and Dys-Methylated Rules.

Authors:  Shiqi Zhang; Tao Zeng; Bin Hu; Yu-Hang Zhang; Kaiyan Feng; Lei Chen; Zhibin Niu; Jianhao Li; Tao Huang; Yu-Dong Cai
Journal:  Front Bioeng Biotechnol       Date:  2020-05-26

8.  Grade Prediction of Bleeding Volume in Cesarean Section of Patients With Pernicious Placenta Previa Based on Deep Learning.

Authors:  Jun Liu; Tao Wu; Yun Peng; Rongguang Luo
Journal:  Front Bioeng Biotechnol       Date:  2020-04-30

9.  Comparison of Different Machine Models Based on Contrast-Enhanced Computed Tomography Radiomic Features to Differentiate High From Low Grade Clear Cell Renal Cell Carcinomas.

Authors:  Xu Pei; Ping Wang; Jia-Liang Ren; Xiao-Ping Yin; Lu-Yao Ma; Yun Wang; Xi Ma; Bu-Lang Gao
Journal:  Front Oncol       Date:  2021-05-26       Impact factor: 6.244

10.  Radiomics models based on enhanced computed tomography to distinguish clear cell from non-clear cell renal cell carcinomas.

Authors:  Ping Wang; Xu Pei; Xiao-Ping Yin; Jia-Liang Ren; Yun Wang; Lu-Yao Ma; Xiao-Guang Du; Bu-Lang Gao
Journal:  Sci Rep       Date:  2021-07-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.